Company: ATMCW
Filing Date: 2025-11-17
Form Type: DEFM14A
Source: 0001493152-25-023842
Chunk: 8

Company: ALPHATIME ACQUISITION CORP
Filing Date: 2025-11-17
Form: DEFM14A
Chunk 8
---
 purposes of the Trial Measures and the Draft Rules Regarding Overseas Listing. Neither the CSRC nor any other PRC regulatory agency or administration has contacted HCYC in connection with HCYC’s or its subsidiary’s operations or proposed Offering. HCYC is currently not required to obtain regulatory approval from the CSRC nor any other PRC authorities for itself and its subsidiary’s operations in Hong Kong and proposed offering. Further, the PRC laws or regulations related to CSRC filings are not enforceable in Hong Kong.

As of the date of this prospectus, HCYC and its operating subsidiary have not received any inquiry, notice, warning or sanctions regarding our planned overseas listing from the China Securities Regulatory Commission or any other PRC governmental authorities. Regardless, if they were required to obtain approval in the future and were denied permission from CSRC or Chinese authorities to list or become quoted on U.S. exchanges and/or quotation servicers, did become subject to PRC laws/authorities, they could incur material costs to ensure compliance, be subject to fines, experience devaluation of securities or delisting, no longer conduct offerings to foreign investors, and no longer be permitted to continue current business operations. This could adversely affect the ability of its securities to trade on Nasdaq as and when qualified. As a result, the value of the securities could significantly decline or become worthless.

Recent statements by the Chinese government have indicated an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investments in China based issuers. Any future action by the Chinese government expanding the categories of industries and companies whose foreign securities offerings are subject to government review could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and could cause the value of such securities to significantly decline or be worthless. Recently, the PRC government initiated a series of regulatory actions and made a number of public statements on the regulation of business operations in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over China-based companies listed overseas using a variable interest entity structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding efforts in anti-monopoly enforcement. As advised by our Hong Kong counsel, as of the date of this prospectus, HCYC and its operating subsidiary are not directly subject to these regulatory actions or statements, as they have not implemented any monopolistic behavior, do not have variable interest entity structure, and our business does not involve the collection of user data, implicate cybersecurity, or involve